Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Blood | 2013-05-02 | PMID 23502220
Hochhaus Andreas, Saglio Giuseppe, Larson Richard A and 11 more
Genes: BCR
